Por favor, use este identificador para citar o enlazar este ítem: https://doi.org/10.14670/HH-18-297

Registro completo de metadatos
Campo DCValorLengua/Idioma
dc.contributor.authorQin, Bo-
dc.contributor.authorZhang, Qi-
dc.contributor.authorChen, Dan-
dc.contributor.authorYu, Hai-yang-
dc.contributor.authorLuo, Ai-xiang-
dc.contributor.authorSuo, Liang-peng-
dc.contributor.authorCai, Yan-
dc.contributor.authorCai, De-yang-
dc.contributor.authorLuo, Jia-
dc.contributor.authorHuang, Ju-fang-
dc.contributor.authorXiong, Kun-
dc.date.accessioned2023-01-16T11:35:12Z-
dc.date.available2023-01-16T11:35:12Z-
dc.date.issued2021-
dc.identifier.citationHistology and Histopathology Vol. 36, nº6 (2021)es
dc.identifier.issn0213-3911-
dc.identifier.issn1699-5848-
dc.identifier.urihttp://hdl.handle.net/10201/127348-
dc.description.abstracty. Mesenchymal stem cells play an important role in tissue damage and repair. This role is mainly due to a paracrine mechanism, and extracellular vesicles (EVs) are an important part of the paracrine function. EVs play a vital role in many aspects of cell homeostasis, physiology, and pathology, and EVs can be used as clinical biomarkers, vaccines, or drug delivery vehicles. A large number of studies have shown that EVs derived from mesenchymal stem cells (MSC-EVs) play an important role in the treatment of various diseases. However, the problems of low production, low retention rate, and poor targeting of MSC-EVs are obstacles to current clinical applications. The engineering transformation of MSC-EVs can make up for those shortcomings, thereby improving treatment efficiency. This review summarizes the latest research progress of MSC-EV direct and indirect engineering transformation from the aspects of improving MSC-EV retention rate, yield, targeting, and MSC-EV visualization research, and proposes some feasible MSC-EV engineering methods of transformation.es
dc.formatapplication/pdfes
dc.format.extent18es
dc.languageenges
dc.publisherUniversidad de Murcia, Departamento de Biologia Celular e Histiologiaes
dc.relationSin financiación externa a la Universidades
dc.rightsinfo:eu-repo/semantics/openAccesses
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectMesenchymal stem cellses
dc.subjectExtracellular vesicleses
dc.subjectEngineeringes
dc.subjectTargetinges
dc.subjectTranslational Medicinees
dc.subjectLoadinges
dc.subject.otherCDU::6 - Ciencias aplicadas::61 - Medicina::616 - Patología. Medicina clínica. Oncologíaes
dc.titleExtracellular vesicles derived from mesenchymal stem cells: A platform that can be engineeredes
dc.typeinfo:eu-repo/semantics/articlees
dc.identifier.doihttps://doi.org/10.14670/HH-18-297-
Aparece en las colecciones:Vol.36, nº6 (2021)

Ficheros en este ítem:
Fichero Descripción TamañoFormato 
Qin-36-615-632-2021.pdf18,97 MBAdobe PDFVista previa
Visualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons